Aptevo Therapeutics
Stock Forecast, Prediction & Price Target

Aptevo Therapeutics Financial Estimates

Aptevo Therapeutics Revenue Estimates

Aptevo Therapeutics EBITDA Estimates

Aptevo Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$12.29M
 
N/A
$3.11M
 
-74.66%
$0
 
-100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $13.21M
Low: $13.21M
High: $13.21M
avg. 0%
Avg: $57.93M
Low: $57.93M
High: $57.93M
avg. 338.33%
Avg: $77.14M
Low: $77.14M
High: $77.14M
avg. 33.14%
Net Income
 
% change YoY
$-27.31M
 
N/A
$42.66M
 
256.22%
$-17.41M
 
-140.80%
Avg: $-31.29M
Low: $-1.60M
High: $-1.60M
avg. -79.75%
Avg: $-18.57M
Low: $-906.48K
High: $-906.48K
avg. 40.65%
Avg: $528.31K
Low: $528.31K
High: $528.31K
avg. 102.84%
Avg: $895.35K
Low: $895.35K
High: $895.35K
avg. 69.47%
EBITDA
 
% change YoY
$-21.4M
 
N/A
$-64.92M
 
-203.37%
$-28.31M
 
56.39%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $-7.93M
Low: $-7.93M
High: $-7.93M
avg. 0%
Avg: $-34.76M
Low: $-34.76M
High: $-34.76M
avg. -338.33%
Avg: $-46.28M
Low: $-46.28M
High: $-46.28M
avg. -33.14%
EPS
 
% change YoY
-$256.35
 
N/A
$366.71
 
243.05%
-$62.62
 
-117.07%
Avg: -$5.77
Low: -$5.77
High: -$5.77
avg. 90.78%
Avg: -$3.26
Low: -$3.26
High: -$3.26
avg. 43.50%
Avg: $1.9
Low: $1.9
High: $1.9
avg. 158.28%
Avg: $3.22
Low: $3.22
High: $3.22
avg. 69.47%
Operating Expenses
 
% change YoY
$33.69M
 
N/A
$31.75M
 
-5.74%
$28.87M
 
-9.05%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $27.46M
Low: $27.46M
High: $27.46M
avg. 0%
Avg: $120.37M
Low: $120.37M
High: $120.37M
avg. 338.33%
Avg: $160.26M
Low: $160.26M
High: $160.26M
avg. 33.14%

FAQ

What is Aptevo Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 33.30% in 2025-2028.

We have gathered data from 1 analysts. Their low estimate is -1.60M, average is -31.29M and high is -1.60M.

What is Aptevo Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 92.86% in 2025-2028.

We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Aptevo Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 90.51% in 2025-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$5.77, average is -$5.77 and high is $-5.77.